Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

14.14
Delayed Data
As of Dec 08
 -0.17 / -1.19%
Today’s Change
11.09
Today|||52-Week Range
22.11
-23.98%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 27.00 and a low estimate of 15.50. The median estimate represents a +76.80% increase from the last price of 14.14.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.34
Sales
$106.5M
Reporting Date
Mar 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 215.86%
 
 
 
 
 
 
Growthannually 51.20%
 
 
 
 
 
 

Sales

Growthquarterly 3.82%
 
 
 
 
 
 
Growthannually 77.94%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.